Recombinant B7-H3 (Enoblituzumab Biosimilar) antibody

Catalog No. ABIN7597664

This anti-B7-H3 (Enoblituzumab Biosimilar) antibody is a Humanized Chimeric antibody detecting B7-H3 (Enoblituzumab Biosimilar) in . Suitable for Human.

Quick Overview for Recombinant B7-H3 (Enoblituzumab Biosimilar) antibody (ABIN7597664)

Target: B7-H3 (Enoblituzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This B7-H3 (Enoblituzumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-B7-H3 (Enoblituzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Enoblituzumab Biosimilar Antibody

Specificity: CD276, B7-H3, Costimulatory molecule, B7H3, 4Ig-B7-H3, B7 homolog 3, CD276 antigen

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 2.04 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for B7-H3 (Enoblituzumab Biosimilar)

Target: B7-H3 (Enoblituzumab Biosimilar)

Alternative Name: Enoblituzumab Biosimilar

Target Type: Biosimilar

Background: CD276, B7-H3, Costimulatory molecule, B7H3, 4Ig-B7-H3, B7 homolog 3, CD276 antigen

UniProt: Q5ZPR3

CAS-No: 1353485-38-7